返回 Agenda
Session 6 Track 3: Balancing the Importance of Global Alignment and Local Execution for the MSL Role
Session Chair(s)
Jim Wilkinson, PHD
U.S. Medical Affairs Lead (Immunology & Payer), Medical Affairs & Evidence Gener, Argenx, United States
In an increasingly interconnected world, medical affairs teams at the global, regional and local level must effectively communicate and collaborate to share actionable insights, create medical strategies, and execute efficiently. This includes coordinated efforts within Field Medical (MSLs) to ensure opinion leaders around the world have valuable interactions with our Field Medical staff. This session will highlight the value that global collaboration can bring to provide one medical voice for the healthcare community. The importance of collaborations between internal stakeholders to align on external engagements and deliverables will be discussed. This will be an interactive session with discussion of best practices and case scenarios.
Learning Objective : At the conclusion of this session, participants should be able to:- Describe the importance of global alignment on MSL strategy and performance with local execution of the MSL activities
- Describe the value of a highly collaborative global team for the creation of MSL strategy, tactical plans, training plans, and medical resources
- Apply learnings from global best practices to inform and positively affect organizational goals of the MSL function
Speaker(s)
Jim Wilkinson, PHD
U.S. Medical Affairs Lead (Immunology & Payer), Medical Affairs & Evidence Gener, Argenx, United States
Speaker
Lori Mouser, PHARMD
Senior Director, Global Head of Oncology Scientific Engagement and Congresses, Daiichi Sankyo Inc., Switzerland
Training and Career Development Contributes to MSL Retention
Jennifer Slade, PHARMD
Senior Director, Global Lead MSLs, Novartis Pharmaceuticals, United States
Speaker